3,000 KRW
24.82 B KRW
152.27 B KRW
5.58 M
About HUMEDIX CO., LTD.
Sector
CEO
Jin-Hwan Kim
Headquarters
Anyang-si
Website
Founded
2003
ISIN
KR7200670008
FIGI
BBG007JSTRW6
Humedix Co., Ltd. engages in the manufacture and sale of hyaluronic acid based medical devices and arthritis treatment products. It offers dermal filler, specialty medicines, ophthalmic solvent, medicine raw materials, and cosmetics. The company was founded on February 27, 2003 and is headquartered in Anyang-si, South Korea.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 200670 is 42,000 KRW — it has decreased by −1.98% in the past 24 hours. Watch HUMEDIX CO., LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange HUMEDIX CO., LTD. stocks are traded under the ticker 200670.
200670 stock has risen by 17.48% compared to the previous week, the month change is a 37.25% rise, over the last year HUMEDIX CO., LTD. has showed a 20.00% increase.
We've gathered analysts' opinions on HUMEDIX CO., LTD. future price: according to them, 200670 price has a max estimate of 57,000.00 KRW and a min estimate of 50,000.00 KRW. Watch 200670 chart and read a more detailed HUMEDIX CO., LTD. stock forecast: see what analysts think of HUMEDIX CO., LTD. and suggest that you do with its stocks.
200670 reached its all-time high on Jun 26, 2015 with the price of 88,150 KRW, and its all-time low was 10,000 KRW and was reached on Mar 19, 2020. View more price dynamics on 200670 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
200670 stock is 6.33% volatile and has beta coefficient of 0.26. Track HUMEDIX CO., LTD. stock price on the chart and check out the list of the most volatile stocks — is HUMEDIX CO., LTD. there?
Today HUMEDIX CO., LTD. has the market capitalization of 432.96 B, it has increased by 9.30% over the last week.
Yes, you can track HUMEDIX CO., LTD. financials in yearly and quarterly reports right on TradingView.
HUMEDIX CO., LTD. revenue for the last quarter amounts to 37.40 B KRW, despite the estimated figure of 45.20 B KRW. In the next quarter, revenue is expected to reach 43.55 B KRW.
200670 net income for the last quarter is 6.83 B KRW, while the quarter before that showed 11.86 B KRW of net income which accounts for −42.37% change. Track more HUMEDIX CO., LTD. financial stats to get the full picture.
HUMEDIX CO., LTD. dividend yield was 1.56% in 2023, and payout ratio reached 20.90%. The year before the numbers were 1.81% and 21.99% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 22, 2024, the company has 334.00 employees. See our rating of the largest employees — is HUMEDIX CO., LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HUMEDIX CO., LTD. EBITDA is 48.88 B KRW, and current EBITDA margin is 31.72%. See more stats in HUMEDIX CO., LTD. financial statements.
Like other stocks, 200670 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HUMEDIX CO., LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HUMEDIX CO., LTD. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HUMEDIX CO., LTD. stock shows the strong buy signal. See more of HUMEDIX CO., LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.